Radioembolization for Hepatocellular Carcinoma using TheraSphere(®)

BACKGROUND/AIM: Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Radioembolization with yttrium-90 (Y90) microspheres is a new concept in radiation therapy for HCC. This review focuses on the indications, efficacy, side effects, and future direction of Y90 therapy,...

Descripción completa

Detalles Bibliográficos
Autor principal: Ali, Safiyya Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
In Focus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122095/
https://www.ncbi.nlm.nih.gov/pubmed/21546728
http://dx.doi.org/10.4103/1319-3767.80388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122095/
https://www.ncbi.nlm.nih.gov/pubmed/21546728
http://dx.doi.org/10.4103/1319-3767.80388

Ejemplares similares